Results

Total Results: 2,327 records

Showing results for "responses".

2181. Arthritis and Nontraumatic Joint Disease (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
      June 01, 2015 - significant improvement in American College of Rheumatology criteria for 20% improvement (ACR20) responses … 66.3%, and 32.6%, and patients whose symptoms did not respond to previous TNF treatment had ASAS20 responses … patients who received secukinumab 75 mg did not have significant improvements in ASAS20 or ASAS40 responses … Using an observed analysis, patients treated with secukinumab 75 mg had ACR 20/50/70 responses of 66.9%

2182. Data-Points-6-Tables (xls file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points-6-tables.xls
      January 01, 2006 - 1 Number of Beneficiaries With at Least One Part A, B, or D Drug Claim for a Biologic of Interest (among continuously enrolled AB FFS population) by Class of Drug and Active Ingredient, 2006-2009 Note: A single period (.) signifies a small cell count (less than 11). Use filters to rank by beneficiary count. …

2183. Effective Health Care (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-radiation_technical-brief.pdf
      November 01, 2009 - Effective Health Care Technical Brief Number 1 Particle Beam Radiation Therapies for Cancer This report is based on research conducted by the Tufts Medical Center Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare R…

2184. Medical Therapies for Children With Autism Spectrum Disorder—An Updaterum Disorder--An Update (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/asd-medical-disposition.pdf
      May 26, 2017 - Comments on draft reviews and the authors’ responses to the comments are posted for public viewing on … The tables below include the responses by the authors of the review to each comment that was submitted … The responses to comments in this disposition report are those of the authors, who are responsible for

2185. Colon-Cancer-Gene-Profiling Research-Protocol (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_research-protocol.pdf
      March 13, 2012 - and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses

2186. The purpose of our tool is to compile a comprehensive list of questions that may be used to evaluate the quality of non-randomized studies of interventions or exposures (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/reliability-testing-grading-evidence_research.pdf
      May 01, 2012 - completed each of the exercises; subsequently, each pair of reviewers reconciled their independent responses … the 10 exercises; subsequently, the two reviewers—i.e., the ―pair‖—reconciled their independent responses … We assigned a numeric value to each of the domains/strength of evidence responses for each reviewer … Agreement improved to fair (AC1=0.22) among pairs of reviewers for the reconciled responses. … Reconciliation Across Reviewer Pairs We received responses from 8 of the 11 pairs describing the approach

2187. Ebctandcfinal (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/ebctandcfinal.pdf
      June 05, 2012 - AHRQ Evidence-Based Care (EBC) Challenge Terms and Conditions Terms and Conditions: By submitting a product in response to the AHRQ Evidence-Based Care (EBC) Challenge, each team and each team member represents and warrants that:  The team and its members are the sole authors, creators, and owners of the pr…

2188. Disposition of Comments for CERs 155 156 Contast-Induced Nephropathy (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_disposition-comments.pdf
      January 07, 2016 - Comments on draft reviews and the authors’ responses to the comments are posted for public viewing on … The tables below include the responses by the authors of the review to each comment that was submitted … The responses to comments in this disposition report are those of the authors, who are responsible for

2189. Core Needle and Open Surgical Biopsy for Diagnosis of Breast Lesions — An Update to the 2009 Report | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/breast-biopsy-update/research-protocol
      December 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

2190. Management of Colonic Diverticulitis | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/diverticulitis/protocol
      October 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

2191. Screening, Behavioral Counseling, and Referral in Primary Care to Reduce Alcohol Misuse | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/alcohol-misuse/research-protocol
      December 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

2192. Diabetes Medications for Adults with Type 2 Diabetes: An Update Focused on Monotherapy and Add-on Therapy to Metformin | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/diabetes-update-2015/research-protocol
      December 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

2193. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_disposition-comments.pdf
      March 10, 2010 - Comments on draft reviews and the authors’ responses to the comments will be posted publicly on the

2194. Hit-Patient-Care Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hit-patient-care_executive.pdf
      June 01, 2012 - Evidence-Based Practice Evidence-based Practice Program The Agency for Healthcare Research and Quality (AHRQ), through its Evidence- based Practice Centers (EPCs), sponsors the development of evidence reports and technology assessments to assist public- and private-sector organizations in their efforts to imp…

2195. Pneumonia-Antibiotic-Treatment Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_executive.pdf
      November 01, 2014 - risk of bias) that used PK/PD measures to study the impact of different antibiotic dosing on clinical responses

2196. Discerning the Perception and Impact of Patients Involved in Evidence-based Practice Center Key Informant Interviews (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/key-informant-interviews-research.pdf
      December 19, 2017 - • “I think it behooves people who are conducting the interview to have some really good responses … that let the person who is responding know that no matter what they 14 say, their responses … Data will be assessed individually and then will be compared and contrasted to the responses the EPC … (2) All audio recordings, transcripts, and background questionnaire responses will be stored on a … All responses will be provided in summary form and will not indicate who said what.

2197. Cancer-Drugs-Utilization-Cost Research (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
      January 01, 2011 - Utilization and cost of anticancer biologic products among Medicare beneficiaries, 2006-2009 Data Points #6Anticancer Biologics From 2006 to 2009, over 800,000 Medicare fee-for-service beneficiaries continuously enrolled in Parts A and B had a claim for an anticancer biologic of interest. Bevacizumab was the m…

2198. • Identify disparities and reasons for disparities and reevaluate the framework for researching disparities The following article was used in answering this question: Davis, L. M., Kilburn, M. R., and Schultz, D. (2009). Reparable Harm:… | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/identify-disparities-and-reasons-for-disparities-and-reevaluate-the-framework-for-researching-disparities-the-following-article-was-used-in-answering-this-question-davis-l-m-kilburn-m-r-and-schultz-d-2009-reparable-harm-asse
      November 01, 2017 - subgroups of patients (e.g., age, race, and common comorbidities) to identify variation in patient responses

2199. Phenylketonuria Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/phenylketonuria_executive.pdf
      February 01, 2012 - Overall, participants’ responses to different dosages of BH4 varied, with individualized dose adjustments

2200. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antiplatelet-treatment_research-protocol.pdf
      November 22, 2011 - Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel … evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses